The accelerator targets high-potential African health-tech startups, which aligns with the applicant's Nigeria-first e-pharmacy platform. The programme's focus on making ventures investment-ready matches the applicant's pre-seed stage and need for structured support. However, the deadline is in the future and the programme may not specifically address the regulatory complexity of prescription-drug infrastructure.